NanoViricides Inc. (NNVC)

[JG36]

Yes, the hype about the current flu-strain-of-the-month might cause the stock price to pop up a bit, before it drifts back down. None of that is relevant to what matters -- actually proving that Flucide is safe and effective in people and getting it to market. H7N9 isn't going to speed that up.

I'm not saying that NNVC shouldn't do in vivo tests of H7N9. It can never hurt to have more evidence that Flucide is effective against a wide variety of influenza strains. But that won't get us any closer to phase I trials.